ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Riccardo Pecori(German Cancer Research Center), Qiang Pan‐Hammarström(Karolinska Institutet), Rafail Nikolaos Tasakis(German Cancer Research Center), Yvonne Fuell(University of Tübingen), Karthika-Devi Selvasaravanan(University of Tübingen), Kui Wu(BGI Group (China)), Dominic Helm(German Cancer Research Center), Rose‐Marie Amini(Uppsala University), Dongbing Liu(BGI Group (China)), Marco Binder(German Cancer Research Center), Mohammad Pirmoradian(Karolinska Institutet), Kristina Sonnevi(Karolinska Institutet), Birgitta Sander(Karolinska University Hospital), Salvatore Di Giorgio(German Cancer Research Center), Weicheng Ren(Tianjin Medical University Cancer Institute and Hospital), Mattias Berglund(Uppsala University), Thorsten Stafforst(University of Tübingen), Sandra Wüst(German Cancer Research Center), Gunilla Enblad(Uppsala University), Björn E. Wahlin(Karolinska University Hospital), Xianhuo Wang(Shanghai Jiao Tong University), F. Nina Papavasiliou(German Cancer Research Center), Wei Li(Harbin Medical University), Xiaobo Li(South China Agricultural University), Xiaofei Ye(Karolinska Institutet), Huilai Zhang(Shanxi Medical University), Annette Arnold(German Cancer Research Center), Martin Schneider(German Cancer Research Center)
Cited by 24
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Genomic basis for RNA alterations in cancer
|Nature|2020|424
Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides
|Nature Biotechnology|2019|295